BEAM
Beam Therapeutics Inc Earnings
$26.39
Earnings Summary
Revenue | $14.27Mn |
Net Profits | $-96.67Mn |
Net Profit Margins | -677.47% |
Beam Therapeutics Inc’s revenue fell -17.01% since last year same period to $14.27Mn in the Q3 2024. On a quarterly growth basis, Beam Therapeutics Inc has generated 21.21% jump in its revenue since last 3-months.
Beam Therapeutics Inc’s net profit fell -0.6% since last year same period to $-96.67Mn in the Q3 2024. On a quarterly growth basis, Beam Therapeutics Inc has generated -6.17% fall in its net profits since last 3-months.
Beam Therapeutics Inc’s net profit margin fell -21.22% since last year same period to -677.47% in the Q3 2024. On a quarterly growth basis, Beam Therapeutics Inc has generated 12.41% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Beam Therapeutics Inc post its latest quarter earningsEPS Estimate Current Quarter | -1.16 |
EPS Estimate Current Year | -1.16 |
Beam Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -1.16 - a -2.65% fall from last quarter’s estimates.
Beam Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -1.16.
Key Ratios
Key ratios of the Beam Therapeutics Inc post its Q3 2024 earningsEarning Per Share (EPS) | -1.17 |
Beam Therapeutics Inc’s earning per share (EPS) jumped 4.1% since last year same period to -1.17 in the Q3 2024. This indicates that the Beam Therapeutics Inc has generated 4.1% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-06 | -1.13 | -1.11 | 1.77% |
2024-11-05 | -1.16 | -1.17 | -0.86% |
2024-03-31 | -1.42 | -1.21 | 14.79% |
₹0 US Stocks a/c Opening Fee